Through this agreement, Xcellbio scientists will work with the Royal Perth Hospital team to develop an automated TIL manufacturing process based on AVATAR platform that achieves key goals for cell ...

Xcell Biosciences Australia PTY LTD (Xcellbio), an affiliate of Xcell Biosciences, Inc., a platform company focused on cell and gene therapy applications, and Royal Perth Hospital announced a ...

Technologies announces its role in supporting Autolus Therapeutics’ FDA approval for AUCATZYL, a recently approved CAR T therapy.

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

Tumor inflitrating lymphocyte therapies are a promising type of cellular immunotherapy used to treat a broad range of solid ...

The quest for effective natural supplements is on the rise, driven by a growing number of individuals seeking improved health ...

Brian Culley; Chief Executive Officer, Director; Lineage Cell Therapeutics Inc Jill Howe; Chief Financial Officer; Lineage Cell Therapeutics Inc Jack Allen; Analyst; Robert W. Baird & Co Inc Thank ...

Brian Culley; Chief Executive Officer, Director; Lineage Cell Therapeutics Inc Jill Howe; Chief Financial Officer; Lineage Cell Therapeutics Inc Jack Allen; Analyst; Robert W. Baird & Co Inc Thank you ...

Lineage Cell Therapeutics reported its Q4 2024 earnings with a notable increase in revenue compared to the previous year, although the company continued to operate at a loss. The stock showed a modest ...

Importantly for everyone listening, it's very important that the process does not change the potency or efficacy of these cells. And so the comparability testing would include all of the customary ...